npj Genomic Medicine (Oct 2022)

A missense variant in the nuclear localization signal of DKC1 causes Hoyeraal-Hreidarsson syndrome

  • Chia-Mei Chu,
  • Hsin-Hui Yu,
  • Tsai-Ling Kao,
  • Yi-Hsuan Chen,
  • Hsuan-Hsuan Lu,
  • En-Ting Wu,
  • Yun-Li Yang,
  • Chin-Hsien Lin,
  • Shin-Yu Lin,
  • Meng-Ju Melody Tsai,
  • Yin-Hsiu Chien,
  • Wuh-Liang Hwu,
  • Wen-Pin Chen,
  • Ni-Chung Lee,
  • Chi-Kang Tseng

DOI
https://doi.org/10.1038/s41525-022-00335-8
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Hoyeraal-Hreidarsson syndrome (HHS) is the most severe form of dyskeratosis congenita (DC) and is caused by mutations in genes involved in telomere maintenance. Here, we identified male siblings from a family with HHS carrying a hemizygous mutation (c.1345C > G, p.R449G), located in the C-terminal nuclear localization signal (NLS) of the DKC1 gene. These patients exhibit progressive cerebellar hypoplasia, recurrent infections, pancytopenia due to bone marrow failure, and short leukocyte telomere lengths. Single-cell RNA sequencing analysis suggested defects in the NLRP3 inflammasome in monocytes and the activation and maturation of NK cells and B cells. In experiments using induced pluripotent stem cells (iPSCs) from patients, DKC1_R449G iPSCs had short telomere lengths due to reduced levels of human telomerase RNA (hTR) and increased cytosolic proportions of DKC1. Treatment with dihydroquinolizinone RG7834 and 3′deoxyanosine cordycepin rescued telomere length in patient-derived iPSCs. Together, our findings not only provide new insights into immunodeficiency in DC patients but also provide treatment options for telomerase insufficiency disorders.